Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

NCT02715024 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Lower Urinary Tract Symptoms
Overactive Bladder
Benign Prostatic Hyperplasia (BPH)

Interventions

DRUG: Tamsulosin
DRUG: Solifenacin

Sponsor

Astellas Pharma Taiwan, Inc.